• There are no suggestions because the search field is empty.
  • Careers
  • Media
  • Investors
  • Contact us
Company
Company
Purpose
Strategy
Leadership
History
Locations
Offering
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights

What are you
looking for?

Company
Purpose
Strategy
Leadership
History
Locations
Offering
Drug Substances
Exclusive synthesis API portfolio Reference standards Preclinical and early-phase development Alkaloid raw materials extraction
Drug Products
Oral solid dosage forms Sterile injectables Ophthalmics Inhalation products Viral vectors
Technologies
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights
  • Careers
  • Media
  • Investors
  • Contact us

Insights

See our event recap

Filter by tags
Technology Early-phase development Sustainability Drug Products Oral solid dosage form
Technology Early-phase development Sustainability Drug Products Oral solid dosage form Regulatory support Scale-up
NEW
07/23/2026
Scale-up Drug Products Oral solid dosage form

Dosage form scale-up: Balancing speed and efficiency in later-stage development

Read article
Recent
Jul 8, 2026
Early-phase development Regulatory support

Navigating the complex route to regulatory compliance, from preclinical to market

Jun 22, 2026
Scale-up Drug Products

The need for speed: Early-stage dosage form development

Apr 2, 2026

Accelerate to win: The challenges of dosage form development

Subscribe for more expert insights

 

All posts
Apr 3, 2024
Technology

The importance of container closure integrity

Jan 9, 2024
Technology

What to look for in a fill & finish partner

Nov 15, 2023
Technology

Maximizing product potential with spray drying

Nov 10, 2023

Safety first: Considerations when formulating high potency compounds

Nov 7, 2023
Technology

Tackling the key challenges in viral vector manufacturing

Sep 28, 2023
Sustainability

Reducing waste up to 15 times through use of membranes

1 2 3 4 5
Oct 30, 2025

Video: Insights from Chief Scientific Officer Stefan Randl at CPHI Frankfurt 2025

Sign up to stay up to date on Siegfried and our business performance.

expect more

Siegfried AG

Untere Brühlstrasse 4
4800 Zofingen, Switzerland
+41 62 746 11 11 Get in touch

About us

  • Our company
  • Sustainability
  • Media
  • Investors
  • Careers

Helpful resources

  • Expert insights
  • News archive
  • Reports
  • Terms and conditions

Offering

  • Drug Substances
  • Drug Products
  • Technologies

2026 © Siegfried Holding AG

  • Privacy Policy
  • Legal disclaimer
  • Imprint